Private Equity Co. Sees Red Over Purple's Poison Pill Plan
By Jeff Montgomery ( February 22, 2023, 7:36 PM EST) -- The largest stockholder of mattress and sleep products maker Purple Innovation Inc. has hit the company's directors with a three-count Delaware Chancery suit targeting an allegedly improper and unjustified adoption of a poison pill and other incumbent board control defenses....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.